Studies have shown that silencing caspase-1 can inhibit the activation of the NLRP3/ASC/caspase-1 axis, reducing myocardial functional impairment caused by ischemia-reperfusion injury (34). Here, CASP1 is linked to ischemia reperfusion injury.